Company Filing History:
Years Active: 1998-1999
Title: Jens Schroder: Innovator in Steroid Chemistry
Introduction
Jens Schroder is a notable inventor based in Jena, Germany. He has made significant contributions to the field of steroid chemistry, particularly in the development of novel substituted steroid compounds. His work focuses on creating more effective agents for the prophylaxis and therapy of radical-mediated cell damage.
Latest Patents
Jens Schroder holds 3 patents, with his latest invention being related to steroids with radical-attracting aromatic substituents. This invention discloses novel substituted steroid compounds that are more effective than known radical-trapping agents. These compounds can be synthesized from steroids with estrane, androstane, pregnane, or cholestane basic skeletons. The compounds feature a radical-attracting aromatic substituent at specific positions of the steroid nucleus, which enhances their therapeutic potential. Additionally, pharmaceutical compositions containing these novel compounds and methods for their production are also part of his patent.
Career Highlights
Throughout his career, Jens Schroder has worked with reputable companies, including Jenapharm GmbH and Jenapharm GmbH & Co. KG. His experience in these organizations has contributed to his expertise in steroid chemistry and innovation.
Collaborations
Jens has collaborated with notable colleagues such as Michael Oettel and Peter Droescher. These partnerships have likely enriched his research and development efforts in the field.
Conclusion
Jens Schroder's innovative work in steroid chemistry and his contributions to the development of novel therapeutic agents highlight his importance as an inventor. His patents reflect a commitment to advancing medical science and improving treatment options for radical-mediated cell damage.